European Journal of Gynaecological Oncology
Print ISSN: 0392-2936 | Online ISSN: 2709-0086
European Journal of Gynaecological Oncology (EJGO) is an international, peer-reviewed, open access journal. EJGO publishes on a broad range of gynaecologic oncology topics. Different types of articles are considered for publication (see Aims & Scope) with emphasis on original research to include prospective clinical trials, basic and applied science, case-control, and cohort studies. We also encourage the submission of systematic reviews and meta-analyses.
Articles
Impact of human papillomavirus status before cervical conization on the clinical course of patients with cervical intraepithelial neoplasia
Impact of human papillomavirus status before cervical conization on the clinical course of patients with cervical intraepithelial neoplasia
DOI: 10.22514/ejgo.2024.089
Comparison of the clinical efficacy of body surface mapping plus wire-guided localization and body surface mapping plus methylene blue-guided localization in occult breast lesions
Comparison of the clinical efficacy of body surface mapping plus wire-guided localization and body surface mapping plus methylene blue-guided localization in occult breast lesions
DOI: 10.22514/ejgo.2024.090
Distance from cancer facility as a barrier to timely treatment among patients with non-metastatic cervical cancer
Distance from cancer facility as a barrier to timely treatment among patients with non-metastatic cervical cancer
DOI: 10.22514/ejgo.2024.091
Serum NSE is an independent risk factor for positive PD-L1 in breast cancer patients
Serum NSE is an independent risk factor for positive PD-L1 in breast cancer patients
DOI: 10.22514/ejgo.2024.092
Exploration of prognostic genes in cervical cancer immune microenvironment
Exploration of prognostic genes in cervical cancer immune microenvironment
DOI: 10.22514/ejgo.2024.093
Promoter's hypermethylation and down-regulated expression of amphiregulin in breast carcinoma: a potential prognostic marker
Promoter's hypermethylation and down-regulated expression of amphiregulin in breast carcinoma: a potential prognostic marker
DOI: 10.22514/ejgo.2024.094
Identification of a 3-cuproptosis-associated-lncRNA-signature that predicts the prognosis of endometrial cancer patients
Identification of a 3-cuproptosis-associated-lncRNA-signature that predicts the prognosis of endometrial cancer patients
DOI: 10.22514/ejgo.2023.073
Exploring the potential of LNCRNA-MEG-3 as a diagnostic and prognostic marker in epithelial ovarian cancer
Exploring the potential of LNCRNA-MEG-3 as a diagnostic and prognostic marker in epithelial ovarian cancer
DOI: 10.22514/ejgo.2024.095
CELSR1 enhances doxorubicin resistance by activating the WNT/PCP signaling pathway in breast cancer cells
CELSR1 enhances doxorubicin resistance by activating the WNT/PCP signaling pathway in breast cancer cells
DOI: 10.22514/ejgo.2024.096
Assessment of oxidative and endoplasmic reticulum stress markers in women with uterine myomas
Assessment of oxidative and endoplasmic reticulum stress markers in women with uterine myomas
DOI: 10.22514/ejgo.2024.097
Clinical study of Modified Ermiao Granules activating AIM2 inflammasome-mediated pyroptosis to clear HR-HPV and ameliorate LSIL
Clinical study of Modified Ermiao Granules activating AIM2 inflammasome-mediated pyroptosis to clear HR-HPV and ameliorate LSIL
DOI: 10.22514/ejgo.2024.098
Correlation of prognostic factors and degree of myometrial invasion in endometrial carcinoma: prospective cohort study
Correlation of prognostic factors and degree of myometrial invasion in endometrial carcinoma: prospective cohort study
DOI: 10.22514/ejgo.2024.099
Apigenin inhibits the proliferation and aerobic glycolysis of endometrial cancer cells by regulating the PI3K/Akt signaling pathway
Apigenin inhibits the proliferation and aerobic glycolysis of endometrial cancer cells by regulating the PI3K/Akt signaling pathway
DOI: 10.22514/ejgo.2024.100
Quality of life and mental health among gynaecological cancer patients towards the end of COVID-19 pandemic
Quality of life and mental health among gynaecological cancer patients towards the end of COVID-19 pandemic
DOI: 10.22514/ejgo.2024.041
APOBEC3G inhibits apoptosis and autophagy in cervical intraepithelial neoplasia W12 cells
APOBEC3G inhibits apoptosis and autophagy in cervical intraepithelial neoplasia W12 cells
DOI: 10.22514/ejgo.2024.101
CRMP4 suppresses cervical cancer cell proliferation and EMT through the Wnt/β-catenin pathway
CRMP4 suppresses cervical cancer cell proliferation and EMT through the Wnt/β-catenin pathway
DOI: 10.22514/ejgo.2024.102
In vitro effects of osteopontin on endometrial cancer cells and signaling pathways in epithelial-mesenchymal transition
In vitro effects of osteopontin on endometrial cancer cells and signaling pathways in epithelial-mesenchymal transition
DOI: 10.22514/ejgo.2024.103
Analysis of current status and influencing factors of cancer-related anorexia in patients undergoing chemotherapy for gynecological malignancies
Analysis of current status and influencing factors of cancer-related anorexia in patients undergoing chemotherapy for gynecological malignancies
DOI: 10.22514/ejgo.2024.104
Combining lenvatinib and pembrolizumab for the management of endometrial carcinosarcoma: a retrospective case series
Combining lenvatinib and pembrolizumab for the management of endometrial carcinosarcoma: a retrospective case series
DOI: 10.22514/ejgo.2024.106
Potential role of TRIM3 as a novel tumour suppressor in endometrial cancer development
Potential role of TRIM3 as a novel tumour suppressor in endometrial cancer development
DOI: 10.22514/ejgo.2024.107
Endometrial cancer risk factors in patients with endometrial echogenicity: a logistic regression analysis
Endometrial cancer risk factors in patients with endometrial echogenicity: a logistic regression analysis
DOI: 10.22514/ejgo.2024.108
Published Ahead of Print
Expression and clinical significance of CSAD in type I endometrial carcinoma
Expression and clinical significance of CSAD in type I endometrial carcinoma
Online publish date: 28 October 2024
DOI: 10.22514/ejgo.2024.110
Nomogram for the prediction of disease-free survival in FIGO 2023 stage IA2 endometrial cancer patients
Nomogram for the prediction of disease-free survival in FIGO 2023 stage IA2 endometrial cancer patients
Online publish date: 26 September 2024
DOI: 10.22514/ejgo.2024.087
Identification of an immune-related metabolic gene signature to predict possible prognosis in endometrial cancer and reveals immune landscape feature
Identification of an immune-related metabolic gene signature to predict possible prognosis in endometrial cancer and reveals immune landscape feature
Online publish date: 15 September 2023
DOI: 10.22514/ejgo.2023.072
Prognostic value of Ki-67 in patients with ovarian cancer
Prognostic value of Ki-67 in patients with ovarian cancer
Online publish date: 24 July 2023
DOI: 10.22514/ejgo.2023.051
Special Issues
Quality of Life in Gynecologic Malignancies
Keywords: Quality of life; Palliative care; Symptom management
Editor: Lori Spoozak, MD
Submission deadline: 31 December 2024
Endometrial Cancer and Fertility Preservation in the Denatality ERA
Keywords: Endoemtrial cancer; Fertility preservation; Surgery fertility sparing; Ovarian reserve
Editor: Dr. Giuseppe Gullo, MD, PhD,Dr. Alessandra Lopez, MD,Dr. Valentina Billone, MD, PhD St.
Submission deadline: 31 December 2025
Advances in Ovarian Cancer Research
Keywords: Ovarian cancer; Cytoreductive surgery; Recurrent ovarian cancer; Retroperitoneal lymphadenectomy; Women cancer global variation
Editor: Basel Refky, MD
Submission deadline: 31 July 2025
Current Update in the Treatment of Cervical Cancer
Keywords: Radical hysterectomy; Fertility Sparing; Oncological Outcomes
Editor: Carlo Ronsini, MD
Submission deadline: 31 December 2024
Gynecological Cancer Prevention: A New Prospective
Keywords: Gynecology; Obstetric and Gynecological Ultrasound; Menopause Obstetrics; Gynecologic Oncology; Gynecologic Pathology
Editor: Ottavia Dʼoria, MD
Submission deadline: 31 October 2023
Molecular Pathological Approach to Uterine Mesenchymal Tumors and Malignant Tumors for the Establishment of New Diagnostic and Therapeutic Methods
Keywords: Leiomyoma; Leiomyosarcoma; Ovarian cancer; Cervical cancer; Endometrial cancer
Editor: Prof. Takuma Hayashi
Submission deadline: 31 October 2023
Molecular Characterization in Endometrial Cancer: Progress and Prospects
Keywords: Endometrial Cancer (EC); Molecular Biomarkers; Immune Checkpoint Inhibitor; Precision Medicine
Editor: Andrea Giannini, MD, PhD
Submission deadline: 31 December 2022
Immunotherapy for Gynecological Oncology
Keywords: Cancer immunotherapy;Cancer vaccination;Immune checkpoint inhibitor;Ovarian cancer;Cervical cancer;Endometrial cancer
Editor: Tadahiro Shoji, MD
Submission deadline: 31 July 2021
Enhanced Recovery of Gynecological Oncology
Keywords: Gynecological Cancer; Enhanced Recovery After Surgery; Minimally Invasive Surgery; Pain Management; Nutritional Support; High Quality Nursing; Psychological Counseling; Complication Management
Editor: Lin Li, MD
Submission deadline: 31 December 2022
Molecular Markers in Ovarian Cancer: Roles in Diagnosis, Prognostic Prediction, and Personalized Therapy
Keywords: Ovarian Cancer;Diagnosis;Prognosis;Treatment Response;Personalized Therapy;Platinum Resistance;Homologous Recombination Deficiency;Immunotherapy;Cytoreduction;Proteomics;Genomics;Prognostic Biomarkers;Diagnostic Biomarkers
Editor: Sharad Ghamande, MD,David Mysona, MD
Submission deadline: 30 March 2022
Featured Article
Real-world bevacizumab utilization and outcomes among women with ovarian cancer in Europe and the United States. DOI: 10.31083/j.ejgo4206181
To Be a Reviewer
If you would like to volunteer to review a manuscript for European Journal of Gynaecological Oncology journal, please click “Review for EJGO” below to register at our submission website or log in our Online Peer Review system. Your name, contact details, and expertise will be automatically added to our database of reviewers.
Review for EJGOJoin Editorial Board
You are welcome to join our editorial board. Our journal produces and issues editorial board certificates for editorial board members, and the journal website will display the names and personal websites of editorial board members to help enhance their scientific influence. Members of the editorial committee are entitled to 1 free publication (both editorial member’s or recommended paper) per year, and other articles over 2 can enjoy 30% discount of publishing fee.
Join Editorial BoardEditor-in-Chief
Prof. Enrique Hernandez, MD, FACOG, FACS.
Dr. Hernandez is the J. Robert Willson Professor and Chair, Obstetrics, Gynecology and Reproductive Sciences of Lewis Katz School of Medicine at Temple University. He is also a professor in Pathology and Laboratory Medicine of Lewis Katz School of Medicine at Temple University. He specializes in comprehensive, compassionate care of women with gynecologic cancer and pre-cancerous conditions, using the most up-to-date and sophisticated diagnostic and treatment tools.